Form 4: Akebia Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4
Nicole R. Hadas, SVP, Chief Legal Officer of Akebia Therapeutics, sold shares to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 29, 2024, Nicole R. Hadas, SVP, Chief Legal Officer of Akebia Therapeutics, sold 5,974 shares of common stock at a price of $1.58 per share.
- The sale was executed automatically by Akebia Therapeutics to cover tax withholding obligations associated with the vesting and settlement of one-third of Hadas' restricted stock units granted on February 28, 2022.
- Following the transaction, Hadas directly owns 663,259 shares of Akebia Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes). It doesn't indicate positive or negative sentiment.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| February 28, 2022 | Date of grant for restricted stock units. |
| February 29, 2024 | Date of stock sale to cover tax obligations. |
| March 01, 2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.